Oral Solid Dosage Pharmaceutical Formulation Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Immediate Release
1.2.3 Extended Release
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Drug Stores
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Perspective (2017-2028)
2.2 Oral Solid Dosage Pharmaceutical Formulation Growth Trends by Region
2.2.1 Oral Solid Dosage Pharmaceutical Formulation Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oral Solid Dosage Pharmaceutical Formulation Historic Market Size by Region (2017-2022)
2.2.3 Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Region (2023-2028)
2.3 Oral Solid Dosage Pharmaceutical Formulation Market Dynamics
2.3.1 Oral Solid Dosage Pharmaceutical Formulation Industry Trends
2.3.2 Oral Solid Dosage Pharmaceutical Formulation Market Drivers
2.3.3 Oral Solid Dosage Pharmaceutical Formulation Market Challenges
2.3.4 Oral Solid Dosage Pharmaceutical Formulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Revenue
3.1.1 Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Revenue (2017-2022)
3.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Players (2017-2022)
3.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Solid Dosage Pharmaceutical Formulation Revenue
3.4 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio
3.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Pharmaceutical Formulation Revenue in 2021
3.5 Oral Solid Dosage Pharmaceutical Formulation Key Players Head office and Area Served
3.6 Key Players Oral Solid Dosage Pharmaceutical Formulation Product Solution and Service
3.7 Date of Enter into Oral Solid Dosage Pharmaceutical Formulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Type
4.1 Global Oral Solid Dosage Pharmaceutical Formulation Historic Market Size by Type (2017-2022)
4.2 Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Type (2023-2028)
5 Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Application
5.1 Global Oral Solid Dosage Pharmaceutical Formulation Historic Market Size by Application (2017-2022)
5.2 Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size (2017-2028)
6.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2017-2022)
6.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (2017-2028)
7.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2017-2022)
7.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (2017-2028)
8.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2017-2022)
8.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (2017-2028)
9.2 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2017-2022)
9.3 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (2017-2028)
10.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2017-2022)
10.3 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Introduction
11.1.4 AstraZeneca Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
11.1.5 AstraZeneca Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Introduction
11.2.4 Bristol-Myers Squibb Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Introduction
11.3.4 Eli Lilly Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
11.3.5 Eli Lilly Recent Development
11.4 Gilead
11.4.1 Gilead Company Detail
11.4.2 Gilead Business Overview
11.4.3 Gilead Oral Solid Dosage Pharmaceutical Formulation Introduction
11.4.4 Gilead Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
11.4.5 Gilead Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Oral Solid Dosage Pharmaceutical Formulation Introduction
11.5.4 Merck Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Introduction
11.6.4 Novartis Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Introduction
11.7.4 Pfizer Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
11.7.5 Pfizer Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Introduction
11.8.4 AbbVie Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
11.8.5 AbbVie Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Detail
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Introduction
11.9.4 Boehringer Ingelheim Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
11.9.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Immediate Release
Table 3. Key Players of Extended Release
Table 4. Key Players of Others
Table 5. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2017-2022)
Table 9. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2023-2028)
Table 11. Oral Solid Dosage Pharmaceutical Formulation Market Trends
Table 12. Oral Solid Dosage Pharmaceutical Formulation Market Drivers
Table 13. Oral Solid Dosage Pharmaceutical Formulation Market Challenges
Table 14. Oral Solid Dosage Pharmaceutical Formulation Market Restraints
Table 15. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Players (2017-2022)
Table 17. Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Pharmaceutical Formulation as of 2021)
Table 18. Ranking of Global Top Oral Solid Dosage Pharmaceutical Formulation Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Oral Solid Dosage Pharmaceutical Formulation Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oral Solid Dosage Pharmaceutical Formulation Product Solution and Service
Table 22. Date of Enter into Oral Solid Dosage Pharmaceutical Formulation Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2017-2022)
Table 26. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2023-2028)
Table 28. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2017-2022)
Table 30. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2023-2028)
Table 32. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2023-2028) & (US$ Million)
Table 42. AstraZeneca Company Detail
Table 43. AstraZeneca Business Overview
Table 44. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product
Table 45. AstraZeneca Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022) & (US$ Million)
Table 46. AstraZeneca Recent Development
Table 47. Bristol-Myers Squibb Company Detail
Table 48. Bristol-Myers Squibb Business Overview
Table 49. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product
Table 50. Bristol-Myers Squibb Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022) & (US$ Million)
Table 51. Bristol-Myers Squibb Recent Development
Table 52. Eli Lilly Company Detail
Table 53. Eli Lilly Business Overview
Table 54. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product
Table 55. Eli Lilly Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022) & (US$ Million)
Table 56. Eli Lilly Recent Development
Table 57. Gilead Company Detail
Table 58. Gilead Business Overview
Table 59. Gilead Oral Solid Dosage Pharmaceutical Formulation Product
Table 60. Gilead Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022) & (US$ Million)
Table 61. Gilead Recent Development
Table 62. Merck Company Detail
Table 63. Merck Business Overview
Table 64. Merck Oral Solid Dosage Pharmaceutical Formulation Product
Table 65. Merck Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Oral Solid Dosage Pharmaceutical Formulation Product
Table 70. Novartis Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Pfizer Company Detail
Table 73. Pfizer Business Overview
Table 74. Pfizer Oral Solid Dosage Pharmaceutical Formulation Product
Table 75. Pfizer Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. AbbVie Company Detail
Table 78. AbbVie Business Overview
Table 79. AbbVie Oral Solid Dosage Pharmaceutical Formulation Product
Table 80. AbbVie Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022) & (US$ Million)
Table 81. AbbVie Recent Development
Table 82. Boehringer Ingelheim Company Detail
Table 83. Boehringer Ingelheim Business Overview
Table 84. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product
Table 85. Boehringer Ingelheim Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022) & (US$ Million)
Table 86. Boehringer Ingelheim Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Type: 2021 VS 2028
Figure 2. Immediate Release Features
Figure 3. Extended Release Features
Figure 4. Others Features
Figure 5. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Application in 2021 & 2028
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Others Case Studies
Figure 10. Oral Solid Dosage Pharmaceutical Formulation Report Years Considered
Figure 11. Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Oral Solid Dosage Pharmaceutical Formulation Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region: 2021 VS 2028
Figure 14. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Players in 2021
Figure 15. Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Pharmaceutical Formulation as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Oral Solid Dosage Pharmaceutical Formulation Revenue in 2021
Figure 17. North America Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2017-2028)
Figure 19. United States Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2017-2028)
Figure 23. Germany Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2017-2028)
Figure 31. China Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2017-2028)
Figure 39. Mexico Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2017-2028)
Figure 43. Turkey Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. AstraZeneca Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
Figure 47. Eli Lilly Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
Figure 48. Gilead Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
Figure 49. Merck Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
Figure 50. Novartis Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
Figure 51. Pfizer Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
Figure 52. AbbVie Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Industry Market Size
